In reply

Affiliations

Comment

Laura Benzonana et al. Anesthesiology. 2014 Jun.

. 2014 Jun;120(6):1524.

doi: 10.1097/ALN.0000000000000247.

¹ Chelsea and Westminster Hospital, Imperial College London, London, United Kingdom (D.M.). d.ma@imperial.ac.uk.

No abstract available

Comment on

Isoflurane, a commonly used volatile anesthetic, enhances renal cancer growth and malignant potential via the hypoxia-inducible factor cellular signaling pathway in vitro.
Benzonana LL, Perry NJ, Watts HR, Yang B, Perry IA, Coombes C, Takata M, Ma D. Benzonana LL, et al. Anesthesiology. 2013 Sep;119(3):593-605. doi: 10.1097/ALN.0b013e31829e47fd. Anesthesiology. 2013. PMID: 23774231
Hypoxia-inducible factors are already "active" in the Von Hippel-Lindau-deficient renal cell carcinoma-4 cells.
Hirota K. Hirota K. Anesthesiology. 2014 Jun;120(6):1523. doi: 10.1097/ALN.0000000000000246. Anesthesiology. 2014. PMID: 24845925 No abstract available.